Circle Wealth Management LLC Sells 446 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Circle Wealth Management LLC lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 7.8% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,250 shares of the health care conglomerate’s stock after selling 446 shares during the quarter. Circle Wealth Management LLC’s holdings in UnitedHealth Group were worth $2,673,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Aveo Capital Partners LLC boosted its stake in shares of UnitedHealth Group by 23.8% in the fourth quarter. Aveo Capital Partners LLC now owns 2,164 shares of the healthcare conglomerate’s stock worth $1,139,000 after purchasing an additional 416 shares during the last quarter. 9258 Wealth Management LLC boosted its stake in UnitedHealth Group by 7.3% in the fourth quarter. 9258 Wealth Management LLC now owns 4,273 shares of the healthcare conglomerate’s stock valued at $2,250,000 after buying an additional 290 shares during the period. Gryphon Financial Partners LLC increased its holdings in shares of UnitedHealth Group by 80.9% during the 4th quarter. Gryphon Financial Partners LLC now owns 6,220 shares of the healthcare conglomerate’s stock worth $3,275,000 after acquiring an additional 2,782 shares during the period. of shares in the respective period. TrinityPoint Wealth LLC raised its stake in UnitedHealth Group by 102.8% during the 4th quarter. TrinityPoint Wealth LLC now owns 14,774 shares of the healthcare conglomerate’s stock valued at $7,778,000 after purchasing an additional 7,489 shares. actions during that period. Finally, ProVise Management Group LLC boosted its position in UnitedHealth Group by 3.0% in the fourth quarter. ProVise Management Group LLC now owns 5,256 shares of the healthcare conglomerate’s stock worth $2,767,000 after purchasing an additional 155 shares during the period. 87.86% of shares are currently owned by institutional investors.

Indoor activity

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available via this link. Also, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s shares.

UnitedHealth Group’s stock performance

Shares of NYSE UNH opened at $575.00 on Friday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $607.94. The company has a current ratio of 0.88, a quick ratio of 0.88, and a debt-to-equity ratio of 0.67. The stock’s 50-day moving average is $577.10 and its 200-day moving average is $520.80. The stock has a market cap of $529.22 billion, a price-to-earnings ratio of 35.15, a P/E/G ratio of 1.64 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH – Get Free Report ) last posted its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping the consensus estimate of $6.66 by $0.14. The company had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. In the same quarter last year, the firm earned $6.14 EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group announces dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be given a $2.10 dividend. The ex-dividend date is Monday, September 16. This represents a dividend of $8.40 on an annualized basis and a yield of 1.46%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Changes in Analyst Ratings

A number of analysts recently commented on the action. HSBC upped their target price on shares of UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. Truist Financial lifted their price target on UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Royal Bank of Canada upped their target price on UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Robert W. Baird boosted their price objective on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. Finally, StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Tuesday, September 17th. One research analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Buy” and an average target price of $614.17.

Check out our latest analysis of UNH

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight and Optum Rx. The UnitedHealthcare segment provides consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses and individuals; health care coverage and health and wellness services for people age 50 and older that address their needs; Medicaid plans, children’s health insurance and health care programs; and health and dental benefits and hospital and clinic services, and health care products and services for state care programs for the economically disadvantaged, medically underserved, and those without funded health care coverage by employer.

Read more

Want to see what other hedge funds own UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).

Get daily news and ratings for UnitedHealth Group – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.